-
Mashup Score: 5
“A blog about allergy, asthma & immunology”
Source: ivancevichmd.blogspot.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 0Omalizumab Drug Survival in Chronic Urticaria: A Retrospective Multicentric French Study - 6 month(s) ago
Omalizumab (OMA) dramatically improves disease control and quality of life in patients with chronic urticaria (CU).
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! #Omalizumab #Drug #Survival in #Chronic #Urticaria: A #Retrospective #Multicentric French #Study https://t.co/XgpiodjFUe https://t.co/fVbsh0P7nC
-
-
Mashup Score: 1
Patients with chronic spontaneous urticaria (CSU) have spontaneous wheals (W), angioedema (AE), or both, for longer than 6 weeks. Clinical differences between patients with standalone W, standalone AE, and W and AE (W+AE) remain incompletely understood.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! #Patients With #Chronic #Spontaneous #Urticaria Who Have #Wheals, #Angioedema, or Both, Differ #Demographically, #Clinically, and in #Response to #Treatment— #Results From CURE https://t.co/vTsthjkW1k https://t.co/XcFjr5ndwc
-
-
Mashup Score: 1
The novel therapeutic approach may be promising for patients with the mast cell-dependent disease, which has limited treatment options despite the substantial burden associated with the condition.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet-
Mast cell silencing may act as a promising approach for cell-mediated diseases like chronic #urticaria, a mast cell-dependent disease, according to a new review published in the European Journal of Allergy and Clinical Immunology. https://t.co/reKZSQEuyP
-
-
Mashup Score: 1Most Patients With Autoimmune Chronic Spontaneous Urticaria Also Have Autoallergic Urticaria, but Not Vice Versa - 8 month(s) ago
Two endotypes of chronic spontaneous urticaria (CSU) associated with mast cell–activating autoantibodies are described, namely autoallergic chronic spontaneous urticaria (aaCSU; with immunoglobulin E [IgE]–anti-autoallergens) and autoimmune chronic spontaneous urticaria (aiCSU; with IgG–anti-high-affinity receptor for the Fc region of immunoglobulin E [FcεRI]/IgE).
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! Most #Patients With #Autoimmune #Chronic #Spontaneous #Urticaria Also Have #Autoallergic Urticaria, but Not Vice Versa https://t.co/UKKhE4MurK https://t.co/JbCYTxL3D0
-
-
Mashup Score: 1Association Between Serum Total IgE Levels and Clinical Response to Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis - 8 month(s) ago
Omalizumab is the only biological agent approved for patients with chronic spontaneous urticaria (CSU), but no biomarker is well established for predicting clinical response to omalizumab.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! Association Between #Serum Total IgE Levels and #Clinical #Response to #Omalizumab for #Chronic #Spontaneous #Urticaria: A Systematic #Review and Meta- #Analysis https://t.co/8FwYKKExhK https://t.co/m4fLvwXtpK
-
-
Mashup Score: 0Chronic Spontaneous Urticaria: The Role and Relevance of Autoreactivity, Autoimmunity, and Autoallergy - 8 month(s) ago
Chronic spontaneous urticaria (CSU) is a frequent and often severely disabling disease. A large number of studies were performed during the last 2 decades to clarify its pathogenesis. These studies shed light on the underlying autoimmune mechanisms of CSU pathogenesis and have led us to understand that different mechanisms may exist and, sometimes, coexist behind the same clinical presentation. The present article reviews the meaning of the terms autoreactivity, autoimmunity, and autoallergy, which have been variably used over the years to define different endotypes of the disease.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! #Chronic #Spontaneous #Urticaria: The Role and Relevance of #Autoreactivity, #Autoimmunity, and #Autoallergy https://t.co/QqI4tnl4VF https://t.co/PvJ7pGnjfj
-
-
Mashup Score: 0Managing Chronic Urticaria and Angioedema: Novel Insights - 9 month(s) ago
Chronic urticaria and angioedema are recurrent conditions that significantly impact patients’ quality of life. Over the past 2 decades, extensive research has been conducted to elucidate the underlying mechanisms and improve the management of these conditions. Recent investigations of the pathophysiology of chronic spontaneous urticaria (CSU) have highlighted the role of autoimmune mechanisms, and 2 endotypes have been characterized: type I autoallergic CSU, associated with immunoglobulin E (IgE) antibodies against autoantigens, and type IIb autoimmune CSU, driven by autoantibodies that activate mast cells, including anti- FcεRI (high-affinity receptor for the Fc region of IgE) and anti-IgE.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet-
In Press (FREE)! #Managing #Chronic #Urticaria and #Angioedema: Novel Insights https://t.co/hzziBZzNyv
-
-
Mashup Score: 4Chronic Urticaria and Angioedema: Masqueraders and Misdiagnoses - 9 month(s) ago
Chronic urticaria is a common condition presenting with intensely pruritic wheals. Although individual lesions resolve within 24 hours, by definition, chronic urticaria lasts for a duration of at least 6 weeks. Both spontaneous and inducible forms exist. In the spontaneous variant, chronic urticaria occurs in the absence of clearly identifiable triggers. In chronic inducible urticaria, specific triggers may include dermatographism, cholinergic (heat), cold, exercise, delayed pressure, and solar.
Source: www.jaci-inpractice.orgCategories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! #Chronic #Urticaria and #Angioedema: Masqueraders and Misdiagnoses https://t.co/IUqWRaBIK6 https://t.co/TlqC503tBT
-
-
Mashup Score: 3Dupilumab Efficacious in Urticaria Symptom, Quality of Life Improvement - 10 month(s) ago
Over 24 weeks, dupilumab demonstrated efficacy in patients with chronic spontaneous urticaria.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
#Dupilumab demonstrated statistically significant improvements to quality of life and urticaria activity in patients with chronic spontaneous #urticaria over a 24-week study period. #DermPAsummer https://t.co/cdwU1dTbm6
-
The effectiveness and safety of a high dose (10 mg) of Desloratadine (Dazit® 10) in treating chronic spontaneous urticaria in India were evaluated in a phase III, multicentric, open-label, single-arm study. Check out the findings here: https://t.co/bmdSnCOsEA #urticaria https://t.co/F81uYq3WXj